Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | GMNN | O75496 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | MTOR | P42345 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | CETP | P11597 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | UBE2N | P61088 | 1/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL139953 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL27963355 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL13825654 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL142855 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL7756046 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL10605211 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL2385582 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL10607850 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL136612 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL10606337 | 1.00 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60081193-A | — | — | None | — | — | JP | disclosed |
| CN-117205156-A | Pressure-sensitive multivesicular liposome for intervening in altitude pulmonary edema, and preparation method and application thereof | 徐州医科大学 | 2023-12-12 | — | — | CN | disclosed |
| EP-1600449-B1 | Process for producing an ester, acetal, ketal, ether or alkyl glycoside | KAO CORP (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-20100152244-A1 | SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-06-17 | — | — | US | disclosed |
| EP-2164465-A1 | SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION | Boehringer Ingelheim International GmbH (DE) | 2010-03-24 | — | — | EP | disclosed |
| WO-2008142090-A1 | SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-11-27 | — | — | WO | disclosed |
| EP-1600449-A1 | Process for producing an ester, acetal, ketal, ether or alkyl glycoside | Kao Corporation (JP) | 2005-11-30 | — | — | EP | disclosed |
| EP-0980869-B1 | ALUMINUM COMPOUNDS AND USE THEREOF | KAO CORP (JP) | 2005-06-08 | — | — | EP | disclosed |
| US-6207845-B1 | ORGANOALUMINUM COMPOUND; ACID CATALYST | KAO CORPORATION (JP) | 2001-03-27 | — | — | US | disclosed |
| EP-0980869-A1 | ALUMINUM COMPOUNDS AND USE THEREOF | Kao Corporation (JP) | 2000-02-23 | — | — | EP | disclosed |
| EP-0138558-B1 | PHOSPHOLIPIDS AND THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1989-07-19 | — | — | EP | disclosed |
| US-4775758-A | Phospholipids | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-10-04 | — | — | US | disclosed |
| JP-S6081193-A | PHOSPHOLIPID | TAKEDA CHEM IND LTD | 1985-05-09 | — | — | JP | disclosed |
| EP-0138558-A2 | Phospholipids and their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152244-A1 | SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION | TTPA, CETP, TYMS | SPHK1 65/4885CYP2D6 39/4885LMNA 3701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.